The pharmaceutical sector's Scope 3 emissions from purchased goods and services total over 272 million tCO2-e, representing more than 80% of the industry's carbon footprint. This webinar highlights how suppliers across the pharmaceutical value chain are driving verified, measurable climate impact and helping companies meet rising ESG expectations.

Join James Connelly, CEO of My Green Lab, to deep dive into the tools empowering pharmaceutical suppliers to deliver verified sustainability performance. He will cover the Converge Supplier Initiative, My Green Lab Certification, the ACT RFP Letter, ACT API integration into purchasing platforms, and the ACT Ecolabel for verified claims. James will also share insights from My Green Lab's 2025 Carbon Impact Report, showing how supplier engagement accelerates Scope 3 reductions. Whether you’re a supplier seeking to differentiate or a pharmaceutical company aiming to strengthen supplier collaboration, this session offers actionable pathways to achieve measurable climate results.

The associated slides for this recording can be found here